Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
Eastwood Bio-Medical Canada Inc. (EBM) September 10, 2018
1 1130-4871 Shell Road, Richmond, BC, Canada V6X 3Z6
This presentation contains forward-looking statements and forward-looking information within the meaning of applicable
securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may",
"will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking
information or statements. The forward-looking statements and information are based on certain key expectations and
assumptions made by the Eastwood Bio-Medical Canada Inc. (the Company) and the Company’s affiliates, including
expectations and assumptions concerning TSX Venture Exchange approvals. Although the Company believes that the
expectations and assumptions on which such forward-looking statements and information are based are reasonable,
undue reliance should not be placed on the forward-looking statements and information because the Company can give no
assurance that they will prove to be correct.
2
Forward-Looking Statement
Disclaimer
Although the data found in this Investor Deck have been produced and processed from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis. Changes may be periodically made to the information herein; these changes may or may not be incorporated in any new versions of this Investor Deck. It is recommended that careful attention be paid to the contents of any information associated with a file, and that the originator of the data or information be contacted with any questions regarding appropriate use. If you find any errors or omissions, please report them to [email protected]. Notwithstanding claims or statements made by any officer, director, employee, related party, or affiliate of Eastwood Bio-medical Canada in any form including written or verbal, EBM makes no claims regarding any products it distributes or manufactures except for the sanctioned claims referred to in slide 4 of this Investor Deck. Readers should consider only these claims when evaluating this document.
3
Disclaimer
Except for the claims allowed by Health Canada Product Licenses 80000196, 80000364, 80000365, 80000477, 80000481, 80000504, 80000866, the Singapore Health Science Authority CDA (HSU) 40:43/01-B(V), the National Pharmaceutical Administration NPA (CPM) 6:06 /1 Vol 19, the Food and Drug Administration Authority (Republic of China) 0900027995, the Food and Drug Administration Authority (Peoples Republic of China) Import Food Hygiene Supervision and Inspection Bureau Certificate 990067, the Food and Drug Administration Authority Approval Number J20060001, neither Eastwood Bio-Medical Canada Inc., its affiliated companies, its employees, its distributors, nor its personnel make any claims that the products distributed by Eastwood Bio-medical Canada cure, diagnose, or, prevent any diseases.
4
Disclaimer
Eastwood Bio-medical Canada Inc. (EBM) is not liable for any information provided on this Investor Deck with regard to recommendations regarding the mentioned products for any health purposes. The products or claims made about specific nutrients or products have not been evaluated by the United States Food and Drug Administration. Dietary products are not intended to treat, prevent or cure disease. Consult with a healthcare professional before starting any diet, supplement or exercise program. EBM makes no guarantee or warranty with respect to any products or services sold. EBM is not responsible for any damages for information provided by the Investor Deck even if EBM has been advised of the possibility of damages. Statements regarding potential health benefits from taking EBM products that appear on this website have not been evaluated by the FDA, and may not have been evaluated by any other governmental body.
5
Eastwood Bio-Medical Canada Inc. is located at Richmond, British
Columbia, Canada near the Vancouver International Airport.
6
Canadian History in Diabetes Leadership
Canada has long been considered the global pioneer of the diabetes industry. In 1922, Frederick Grant Banting discovered insulin, which is considered one of the most important discoveries of the 20th century. The Nobel Foundation awarded his team the Nobel Prize in Physiology and Medicine in 1923.
7
Who We Are
A company specializing in metabolic disorders such as diabetes, obesity, hypertension, and Alzheimer’s disease. We have successfully developed over 70 Eleotin® products including over 60 Health Canada (Canadian FDA) approved products. Advertising Standards Canada (ASC) approved our flagship product,
Eleotin® Bentley to be marketed as “World’s #1 Doctor recommended Natural Source Healthy Blood Glucose Promoting Product available in Canada”.
Company Background and Highlights
8 Please see Disclaimers on slides 3, 4, and 5.
9
Advertising Standards Canada Approval Number
Please see Disclaimers on slides 3, 4, and 5.
Who We Are
10
As of 2018, over 500,000 users are estimated to have used and benefited from Eleotin® . (An estimated 200,000 users as of 2014, or as of the ASC approval stamp) More than four international health associations strongly recommend (endorsed) Eleotin® . Eleotin® was the recipient of Best Diabetic & Hypertension Management Drug of the Year 2010*, and 7th Annual International Brand Packaging Gold Award. *Institute for Government Research & Leadership Technology, Nigeria Please see Disclaimers on slides 3, 4, and 5.
EBM: The Recent Focus of Financial Analysts and Investors
Company production capacity ‘recently’ has increased to:
▰ Up to 3 million capsules can be produced and 10,000 bottles can be packaged per day.
▰ A half million dollar worth of products in retail value can be produced daily.
▰ Up to $7 million in possible savings in annual manufacturing costs.
11
EBM: The Recent Focus of Financial Analysts and Investors
12
EBM: The Recent Focus of Financial Analysts and Investors
13
New Product Approvals and Licenses (68 NPN Numbers).
DRAFT
June 29 2018, Eastwood Bio-Medical Canada Enters Binding Terms for Asian Exports
▰ On June 29 2018, EBM announced entering binding terms for Asian exports. The Company is optimistic that this will result in an increase in revenues.
▰ New manufacturing capabilities allow the Company to finally start producing highly advanced and complex products with the best quality and process control on a meaningfully larger scale.
▰ The facilities and operations meet Good Manufacturing Practices standards, and retain site licenses from Health Canada and a foreign government.
▰ EBM is no longer being bound by production limitations.
14
Stock Prices in the Past 6
Months
15
The market has begun paying attention.
Apr 9 May 14 Jun 11 Jul 9 Aug 6 Sep 3
Trading Volume in the Past 6 Months
629 K
16
Sep 3
Aug 6
Jul 9 Jun 11
May 14
Apr 9
800k
Market Potential: Prevalence of Diabetes By IDF Region
17
Global Report on Diabetes – WHO 2016
Market Potential: Prevalence of Alzheimer’s and Dementia
18
World Alzheimer's Report 2015
Market Potential: Prevalence of Hypertension
19
Global Prevalence of Hypertension over 1.3 Billion
Global Health Observatory - WHO 2013
Market Values of Diabetes, Hypertension and Alzheimer’s
20
▰ Type 2 diabetes market to more than double, to $64 billion by 20261
▰ Global hypertension market will reach USD $32 billion by the end of 20202
▰ The global Alzheimer's market is expected to $10.4 billion in 20213
1. GlobalData’s report: PharmaPoint: Type 2 Diabetes – Global Drug Forecast and Market Analysis to 2026 2. Technavio 3. GBI Research - Alzheimer's Disease Therapeutics Market to 2021
Our Claim: The Only Option
21
We believe that our products are the ‘only’ natural sourced option for those inflicted with these diseases. We also believe we will remain the only option in the near future. Here is why... Please see Disclaimers on slides 3, 4, and 5.
22
Pharmaceutical Drugs and
Insulin
Other Herbal Products
Traditional Chinese Medicine
Folkloric Treatments/ Alternative Treatments
Eleotin®
Known - Can be used with other pharmaceutical
drugs
Unknown Unknown Unknown
Known - Can be safely used with
other pharmaceutical
drugs
Please see Disclaimers on slides 3, 4, and 5.
Advantage #1: Modes of Action Known
● The Modes of Actions for most non-pharmaceutical treatments are unproven. They can not be used with pharmaceutical drugs out of fear of unknown adverse interactions.
● Eleotin® 's modes of actions are known and proven. Eleotin® is safe when used with oral pharmaceutical drugs and insulin.
● In fact, Eleotin® reduces the side effects and resistance of oral pharmaceutical drugs and insulin. When used with Eleotin® , oral pharmaceutical drugs and insulin become safer, more efficacious, and less habit forming.
23
Pharmaceutical Drugs and
Insulin
Other Herbal Products
Traditional Chinese Medicine
Folkloric Treatments/ Alternative Treatments
Eleotin®
None None Unknown None Semi-
permanent efficacy
Advantage #2: Long Term Effects
● With proven insulin resistance reduction, Eleotin® provides semi-permanent long term improvement while other treatments do not give such long term benefits.
● Most other treatments only have short term control benefits, and must be used permanently.
● But a person can stop Eleotin® with no harmful side effects after the body has a attained structural change.
For more information, please contact [email protected] Please see Disclaimers on slides 3, 4, and 5.
24
Pharmaceutical Drugs and
Insulin
Other Herbal Products
Traditional Chinese Medicine
Folkloric Treatments/ Alternative Treatments
Eleotin®
No No No No Yes
Advantage #3: Preventive Effects
● A person who does not have diabetes can use Eleotin® for general health and preventive purposes. Other treatments do not offer such safe options.
Please see Disclaimers on slides 3, 4, and 5.
25
Pharmaceutical Drugs and Insulin
Other Herbal Products
Traditional Chinese Medicine
Folkloric Treatments/ Alternative Treatments
Eleotin®
Short term and invasive
treatment. Toxic and severe side
effects. Resistance develops. Ever
increasing dosages.
Shotgun approach. Most of them rely
on artificial indigestion to lower
the blood sugar.
Shotgun approach. Most of them rely
on artificial indigestion to lower
the blood sugar.
Shotgun approach. Most of them rely
on artificial indigestion to lower
the blood sugar.
Long term and safe beneficial
effects. General health
improvements.
Conclusion
● If you compare Eleotin® with other treatments from all perspectives, it’s natural to conclude that Eleotin® is the only natural sourced option.
Please see Disclaimers on slides 3, 4, and 5.
26
Advertising Standards Canada (ASC) approved Eleotin® to be marketed as “World’s #1 Doctor recommended Natural Source Healthy Blood Glucose Promoting Product available in Canada”.
● World’s No.1 Doctor recommended: Over 3000+ doctors
● Over 2,500 Newspaper & Television Acclaims (including New York Times
#1 Best Sellers)
● Researched/Clinically tested by Universities and Governments
● Strongly recommended by more than 4 Associations
● Licenses issued by 8 Government Authorities
● Best Diabetic & Hypertension Management Drug of the Year 2010*
● As of 2018, more than 500,000 Users, and over 2,000 Youtube
testimonials
As a Result,
*Institute for Government Research & Leadership Technology, Nigeria Please see Disclaimers on slides 3, 4, and 5.
International Health Associations Endorsements of Eleotin ®
27 These are unsolicited third party opinions from unaffiliated individuals based on their own independent research. Except for claims referred to on slides 3, 4, and 5, EBM takes no responsibility for any claims.
28
Recommendations of Medical Professionals
These are unsolicited third party opinions from unaffiliated individuals based on their own independent research. Except for claims referred to on slides 3, 4, and 5, EBM takes no responsibility for any claims.
Dr. Chu, Beijing China “Because of Eleotin my husband doesn’t need any pharmaceutical drugs. He’s normal now.”
Dr. L. Lipskaya, Bacteriologist “After I started using Eleotin, I felt an improvement in my health conditions. Now I recommend Eleotin to every person who are suffering from Type II diabetes.”
Dr. P. Singh Ayurvedic Medicine “I want to recommend Eleotin especially to Type II diabetics. It will help them in controlling their blood glucose levels.”
Dr. C. L. Broadhurst “Eleotin is blend of many promising herbs that dramatically lower blood sugar.”
Dr. D. Walker “Eleotin is effective in regulating blood glucose levels. ”
Dr. M. Sichel “A pathfinding discovery in the reversal of diabetes.”
Dr. E. Echano “Everyone should know about this. I observed excellent clinical result. This unique herbal formulations long lasting effects are truly amazing.”
Clinical Studies, Publications, Approvals, and Licenses
29
Please see Disclaimers on slides 3, 4, and 5.
Clinical Studies, Publications, Approvals, and Licenses
30 Please see Disclaimers on slides 3, 4, and 5.
Clinical Studies, Publications, Approvals, and Licenses
31
Comments on Eleotin® by the Korean National Diabetes Association
Please see Disclaimers on slides 3, 4, and 5.
Clinical Studies, Publications, Approvals, and Licenses
32
Comments on Eleotin® by the Korean Pharmaceutical Manufacturers’ Association
Please see Disclaimers on slides 3, 4, and 5.
Africa's Best Diabetic & Hypertension Management Drug in 2010*
33
*These are unsolicited third party opinions based on independent research. Except for claims referred to on slides 3, 4, and 5, EBM takes no responsibility for any claims. Please see Disclaimers on
slides 3, 4, and 5.
Testimonials
34
We have over 5,000 video testimonials on Youtube by users and doctors with all real names and many contact information to verify. Please see Disclaimers on slides 3, 4, and 5.
Established Retail Lines
35
Eleotin® Bentley ● Helps promote healthy glucose
levels. ● Long-term blood glucose.
normalization effects. ● General health improvement.
Eleotin® Ma5 ● Powerful anti-oxidation powers that are
preserved superbly. ● High quality Vitamin C group
ingredients.
Established Retail Lines
Eleotin® LBM ● For hyperactivity of the liver (high
blood pressure). ● To cut the vicious cycle between high
blood sugar and high blood pressure caused by prescription drugs.
Eleotin® Pedo-Protection Socks ● Anti-Fungal & Anti-Bacterial. ● Auto Regulating Mesh Top. ● Treated Inner Toe Seam. ● Holistic & Gentle Neck Pressure.
36
Founder - Dr. Youngsoo Kim
● Advises Various Governments and senior
management of numerous Korean firms
including Hyundai, Gold Star, and Samsung
● CEO of Mutsumi Enterprises Canada Corp.
1991-1995
● Vice President of Toshin Butsuryu
(Toyota Automobile Group Japan) 1991-1995
● Protocol secretary in the Korean Presidential
Palace 1987
● Assistant Professor of Finance at the
University of Alberta in Edmonton 1987
● Massachusetts Institute of Technology
(Ph.D. in Economics) 1987
37
Board of Directors
Yunji Kim President, CEO and Director
● President since April 2013, Director since October 2012
● New York State Bar admission 2012
● LL.M. in Taxation, Georgetown University Law Center, 2011
38
Peter Chen CFO and Director
● Executive Director of Proterra Management Group Inc.
Dr. Marcus Kuypers Director
● Medical Doctor ● Physician at AB
Staffing since November 2011
● Accretive Health from October 2011 to February 2013
● Doctors Home Visits from September 2001 to August 2011
● Emergency Medicine physician since November 2011
Dr. Terrance Owen Director
● Director of Pacific Paredyme Energy Inc.
● CEO of CellMedX Corp. ● President and CEO of
Nuva Pharmaceuticals Inc. until June 2013
Appendix - Financial Information
39
Most updated information available upon request
www.eleotin.ca
Yunji Kim Unit 1130-4871 Shell Road Richmond, B.C. Canada, V6X 3Z6
604.247.2100 or 1.888.669.4372 [email protected]
www.eleotin.ca
40